Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_assertion type Assertion NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_head.
- NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_provenance.
- NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_assertion evidence source_evidence_literature NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_provenance.
- NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_assertion SIO_000772 22511072 NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_provenance.
- NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_assertion wasDerivedFrom befree-2016 NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_provenance.
- NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_assertion wasGeneratedBy ECO_0000203 NP975617.RAq-WictsDs-pagM7dDfOa4ktsqKOFuIAttk4AH8PTAf8130_provenance.